Related references
Note: Only part of the references are listed.Elucidation of Cellular Mechanisms Involved in Experimental Paromomycin Resistance in Leishmania donovani
Vasundhra Bhandari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
An overview of visceral leishmaniasis elimination program in India: a picture imperfect
Ubhayabharathi Gurunath et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L-infantum
S. Hendrickx et al.
PARASITOLOGY RESEARCH (2014)
Antimony Resistant Leishmania donovani but Not Sensitive Ones Drives Greater Frequency of Potent T-Regulatory Cells upon Interaction with Human PBMCs: Role of IL-10 and TGF-β in Early Immune Response
Rajan Guha et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
A novel marker, ARM58, confers antimony resistance to Leishmania spp.
Andrea Nuehs et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)
Drug-resistant microorganisms with a higher fitness - can medicines boost pathogens?
Manu Vanaerschot et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2013)
Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach
Elham Kazemi-Rad et al.
EXPERIMENTAL PARASITOLOGY (2013)
Quantification of Candida albicans by flow cytometry using TO-PRO®-3 iodide as a single-stain viability dye
Monique Kerstens et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2013)
Virulence loss and amastigote transformation failure determine host cell responses to Leishmania mexicana
K. S. Ali et al.
PARASITE IMMUNOLOGY (2013)
Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1
Budhaditya Mukherjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex
Tim Downing et al.
INFECTION GENETICS AND EVOLUTION (2012)
Genetic Markers for SSG Resistance in Leishmania donovani and SSG Treatment Failure in Visceral Leishmaniasis Patients of the Indian Subcontinent
Manu Vanaerschot et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Impact of Continuous Axenic Cultivation in Leishmania infantum Virulence
Diana Moreira et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol
Sarah Hendrickx et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Leishmania Metacyclogenesis Is Promoted in the Absence of Purines
Tiago Donatelli Serafim et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Leishmania donovani Develops Resistance to Drug Combinations
Raquel Garcia-Hernandez et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Tim Downing et al.
GENOME RESEARCH (2011)
Characterisation of antimony-resistant Leishmania donovani isolates: Biochemical and biophysical studies and interaction with host cells
Rupkatha Mukhopadhyay et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2011)
Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines
M. Ouakad et al.
PARASITOLOGY (2011)
Leishmania antimony resistance: what we know what we can learn from the field
Khatima Ait-Oudhia et al.
PARASITOLOGY RESEARCH (2011)
Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden
Manu Vanaerschot et al.
PLOS ONE (2011)
The fitness of antimony-resistant Leishmania parasites: lessons from the field
Khatima Ait-Oudhia et al.
TRENDS IN PARASITOLOGY (2011)
Drug Resistance in Visceral Leishmaniasis
Helena C. Maltezou
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Combination therapy for visceral leishmaniasis
Johan van Griensven et al.
LANCET INFECTIOUS DISEASES (2010)
Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani Strains
Manu Vanaerschot et al.
PLOS ONE (2010)
Antimony Toxicity
Shyam Sundar et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2010)
Drug Resistance in Leishmaniasis
Jaya Chakravarty et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2010)
In Vitro Sensitivity Testing of Leishmania Clinical Field Isolates: Preconditioning of Promastigotes Enhances Infectivity for Macrophage Host Cells
Raquel Inocencio da Luz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Fitness and its role in evolutionary genetics
H. Allen Orr
NATURE REVIEWS GENETICS (2009)
Paromomycin
Robert N. Davidson et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2009)
The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist
Peter E. Kima
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Leishmania spp.:: proficiency of drug-resistant parasites
Sonimar Natera et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani
Hema Kothari et al.
PARASITOLOGY INTERNATIONAL (2007)
Intra-specific variability of virulence in Leishmania infantum zymodeme MON-1 strains
Teresa Baptista-Fernandes et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2007)
Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana
HI Al-Mohammed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Infectivity and virulence of Leishmania donovani promastigotes:: A role for media, source, and strain of parasite
T Dey et al.
JOURNAL OF EUKARYOTIC MICROBIOLOGY (2002)
Drug resistance in Indian visceral leishmaniasis
S Sundar
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Share Paper
